Ulf Björklund
Surgical
redwoodpharma
Sweden
Biography
More than 30 years’ experience within Life Science industry, Held many different roles, primarily in clinical development within Kabi Pharmacia AB, Pharmacia & Upjohn / Pharmacia during a 15 year period, Project group member that developed and launched Xalatan (glaucoma) Other prior appointments include CEO of OxyPharma AB and Aprea AB Current assignments include consulting and board work within pharmaceutical drug development
Research Interest
pharmaceutical drug development
